Evidence map›Paper›PMID 42717169›Full record

ArticleAAPS PharmSciTech2026

Correlative Spectroscopic and Structural Imaging for Resin-Embedded Extended-Release Morphine Sulfate Pellets.

Yeakub Zaker, Snober Ahmed, Li Tian, Huzeyfe Yilmaz, Changning Guo, Jason D Rodriguez, Daniel R Willett

Abstract read
PubMed Publisher
In one paragraph

Article in AAPS PharmSciTech, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yeakub ZakerFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA.ORCID http://orcid.org/0000-0002-4192-0984
Snober AhmedFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA.ORCID http://orcid.org/0009-0003-6491-2113
Li TianFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA.ORCID http://orcid.org/0000-0001-8048-4874
Huzeyfe YilmazFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA.ORCID http://orcid.org/0000-0003-1595-7019
Changning GuoFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA.ORCID http://orcid.org/0009-0001-5149-9257
Jason D RodriguezFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA.ORCID http://orcid.org/0000-0002-8814-1144
Daniel R WillettFood and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality Research (OPQR), Division of Pharmaceutical Quality Research II (DPQR II), 645 S. Newstead Ave, St. Louis, Missouri, 63110, USA. daniel.willett@fda.hhs.gov.ORCID http://orcid.org/0000-0002-7490-4251

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Correlative spectroscopic and structural imaging provides a powerful approach for characterizing the microstructure of complex pharmaceutical formulations. Laser direct infrared (LDIR) spectroscopy is an emerging, rapid spectroscopic imaging technique that complements traditional approaches by enabling non-destructive chemical and morphological analysis over large sample surfaces within minutes. In this study, the capabilities of LDIR imaging were evaluated alongside Raman mapping, SEM-EDS, laser microscopy, and micro-CT as part of a correlative workflow to characterize the microstructure and chemical composition of pharmaceutical pellets. Resin embedding enabled consistent handling and structural preservation of extended-release pharmaceutical pellets across all imaging modalities. Two commercially available morphine sulfate ER pellets (ER-1 and ER-2) with different excipient compositions were used as model systems. Laser microscopy revealed distinct differences in surface topography, while micro-CT performed before milling confirmed inherent structural features. ER-1 displayed a smooth, intact core, whereas ER-2 exhibited internal cracks and cavities. Hyperspectral LDIR imaging successfully identified major components in both formulations (hit-quality index, HQI ≥ 0.83) with strong concordance to Raman mapping (HQI ≥ 0.85). The spatial distribution of the active pharmaceutical ingredient (API) revealed a layered structure in ER-1 and a homogeneous core in ER-2. This correlative workflow, combining resin embedding with multiple imaging modalities, underscores the value of LDIR and complementary techniques for comprehensive physicochemical characterization of complex drug products. These findings highlight the utility of correlative imaging for regulatory assessment and quality control of complex extended-release formulations.

Indexed as

Delayed-Action PreparationsMorphineBulk DrugsChemistry, PharmaceuticalDrug CompoundingDrug ImplantsExcipientsSpectrum Analysis, RamanX-Ray MicrotomographyBulk DrugsDelayed-Action PreparationsDrug ImplantsExcipientsMorphineextended-release pelletLDIR imagingmicro-CTpharmaceutical analysisRaman mapping

Identifiers

PMID42717169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.